
Santen Pharmaceutical
North America, California, United States, Emeryville
Description
Santen sells ophthalmic products.
Investor Profile
Santen Pharmaceutical has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 33% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, Japan, Singapore.
- Strong thematic focus on Biotechnology, Health Care, Medical Device.
Stage Focus
- Series A (22%)
- Series B (22%)
- Series C (11%)
- Series F (11%)
- Debt Financing (11%)
- Series Unknown (11%)
- Corporate Round (11%)
Country Focus
- United States (67%)
- Japan (22%)
- Singapore (11%)
Industry Focus
- Biotechnology
- Health Care
- Medical Device
- Medical
- Pharmaceutical
- Therapeutics
- Laser
- Semiconductor
- Eyewear
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Santen Pharmaceutical frequently co-invest with?
Which angels does Santen Pharmaceutical often collaborate with?
What are some of recent deals done by Santen Pharmaceutical?
Find More Investors Like Santen Pharmaceutical
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










